BioSig Technologies Inc ( OTCMKTS:BSGM) Gaining More Ground

[[tagnumber 0]][[tagnumber 1]]BioSig Technologies Inc (OTCMKTS:BSGM) was quite volatile in the beginning of this year and we saw the ticker swaying in both directions on increased volumes. The company stock was touted by SeeThruEquity, setting a twelve–month price target of $3.53 per share.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]That seems a bit steep for a stock such as [[tagnumber 6]]BSGM,[[tagnumber 7]] but the company’s financial state has actually improved. The financial report for the fiscal 2015 was filed in the middle of last month and it contained the following numbers of prime interest in its balance sheet.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $953 thousand[[tagnumber 13]] [[tagnumber 12]]current assets: $984 thousand[[tagnumber 13]] [[tagnumber 12]]current liabilities: $2.47 million[[tagnumber 13]] [[tagnumber 12]]revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]net loss: $9.46 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The cash reserves seem a lot better, but the liabilities have also grown. The net loss is also considerable, but the market cap of $36 million isn’t that big for a medical company, even by OTC standards.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Earlier this month we saw [[tagnumber 6]]BSGM[[tagnumber 7]] embark on an upward climb and the ticker has managed to close six consecutive sessions in the green so far. Yesterday we saw it gain 9.76% in value and close at $2.0799, while a total of 78 thousand traded share generated $159 thousand in daily dollar volume.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Looking at today’s trading [[tagnumber 6]]BSGM[[tagnumber 7]] will likely see a green close of this week as well. Still, that doesn’t mean that you should skip on doing your due diligence and weighing out the risks before putting any money on the line.[[tagnumber 2]]